11.42 am | 20 May 2013 |  Source: Moneycontrol.com

Lupin is the second company which launched the generic version of anti-cholesterol drug Tricor in November 2012. Tricor is a fairly big contributor to...

11.12 am | 20 May 2013 |  Source: Reuters

Mylan Inc said in a statement on Friday its unit Mylan Pharmaceuticals Inc has shipped generic Tricor, or fenofibrate tablets, of 48 mg and 145 mg. My...

8.32 pm | 17 May 2013 |  Source: CNBC-TV18

Investors must focus on mid cap companies now as market is likely to consolidate after a huge rally and large caps may not offer similar gains as earl...

7.36 pm | 17 May 2013 |  Source: CNBC-TV18

Vishal B Malkan of malkansview.com is of the view that Lupin, IndusInd Bank, Yes Bank and McDowell Holdings are best bets, one can add the stock on ev...

7.17 pm | 17 May 2013 |  Source: CNBC-TV18

Market experts advise investors to adopt a stock-specific approach to the market which closed on a consolidatory note on Friday and bet on the experts...

4.53 pm | 17 May 2013 |  Source: CNBC-TV18

Aashish Tater, Head of Research, Fortunewizard.com is of the view that Lupin, Sun Pharmaceutical Industries and Dr Reddys Laboratories are safe bets. ...

11.08 am | 17 May 2013 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com is of the view that one can buy Lupin on dips....

10.36 am | 17 May 2013 |  Source: Moneycontrol.com

The Department of Pharmaceuticals on Thursday notified Drug Price Control Order 2013. Once implemented over next few months, prices of 348 essential d...

5.18 pm | 16 May 2013 |  Source: CNBC-TV18

Short-term traders can take long position in Lupin on intraday dips, says Sudarshan Sukhani of s2analytics.com....

10.38 am | 15 May 2013 |  Source: CNBC-TV18

For the index to touch 6100, Reliance Industries, Infosys and TCS will have to perform, says Vineet Bhatnagar opf Phillip Capital. He is bullish on p...

7.13 pm | 14 May 2013 |  Source: Moneycontrol.com

After last week's rally experts believe that Nifty will be drifting downward for few more sessions and hence short bias is advised. Q4 GDP data would ...

1.01 pm | 14 May 2013 |  Source: CNBC-TV18

Bhuvnesh Singh, head of research at Barclays Capital says at Barclays they are overweight on healthcare stocks, some pharma stocks like Sun Lupin. The...

3.29 pm | 13 May 2013 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com is of the view that one can buy Lupin on correction....

10.25 am | 10 May 2013 |  Source: CNBC-TV18

Hemant Thukral of Aditya Birla Money recommends investors to sell only if the Nifty goes below 6025 because he believes the momentum of the market is ...

8.49 pm | 09 May 2013 |  Source: CNBC-TV18

CNBC-TV18’s Archana Shukla reports that the pharma sector’s fortunes in the January-March quarter were dictated by the US market while the sector'...

4.46 pm | 09 May 2013 |  Source: CNBC-TV18

CLSA expects Zee Entertainment weightage cut in half. This would mean that there will be a selling pressure of close to USD 36-40 million....

4.39 pm | 09 May 2013 |  Source: CNBC-TV18

According to VK Sharma of HDFC Securities, pharma is still a better bet than IT. He said he would replace any IT stock with Lupin....

1.12 pm | 09 May 2013 |  Source: CNBC-TV18

In an interview to CNBC-TV18, Manoj Garg, VP, Institutional Equities - Research, Edelweiss Securities shares his outlook on the pharmaceutical compani...

7.09 pm | 08 May 2013 |  Source: CNBC-TV18

Kamal Sharma, MD, Lupin Ltd says, in an interview to CNBC-TV18, that the attention to margins, quality and control on costs caused fourth-quarter net ...

6.59 pm | 08 May 2013 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com, SP Tulsian of sptulsian.com and Dipan Mehta, member, BSE and NSE advise investors to await a further rally by th...